These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


356 related items for PubMed ID: 30071518

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
    King BF, Torres VE, Brummer ME, Chapman AB, Bae KT, Glockner JF, Arya K, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).
    Kidney Int; 2003 Dec; 64(6):2214-21. PubMed ID: 14633145
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M, Inci A.
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease.
    Muto S, Kawano H, Isotani S, Ide H, Horie S.
    Clin Exp Nephrol; 2018 Jun; 22(3):583-590. PubMed ID: 29101551
    [Abstract] [Full Text] [Related]

  • 28. Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry.
    Breysem L, De Keyzer F, Schellekens P, Dachy A, De Rechter S, Janssens P, Vennekens R, Bammens B, Irazabal MV, Van Ongeval C, Harris PC, Mekahli D, CRISP Consortium.
    Clin J Am Soc Nephrol; 2023 May 01; 18(5):581-591. PubMed ID: 36800517
    [Abstract] [Full Text] [Related]

  • 29. Ultrasonographic renal volume measurements in early autosomal dominant polycystic disease: comparison with CT-scan renal volume calculations.
    Hammoud S, Tissier AM, Elie C, Pousset M, Knebelman B, Joly D, Hélénon O, Correas JM.
    Diagn Interv Imaging; 2015 Jan 01; 96(1):65-71. PubMed ID: 25547671
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.
    Sharma K, Caroli A, Quach LV, Petzold K, Bozzetto M, Serra AL, Remuzzi G, Remuzzi A.
    PLoS One; 2017 Jan 01; 12(5):e0178488. PubMed ID: 28558028
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease.
    King BF, Reed JE, Bergstralh EJ, Sheedy PF, Torres VE.
    J Am Soc Nephrol; 2000 Aug 01; 11(8):1505-1511. PubMed ID: 10906164
    [Abstract] [Full Text] [Related]

  • 34. Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.
    Lee YR, Lee KB.
    Nephron Clin Pract; 2006 Aug 01; 103(4):c173-80. PubMed ID: 16636585
    [Abstract] [Full Text] [Related]

  • 35. Comparison of MRI segmentation techniques for measuring liver cyst volumes in autosomal dominant polycystic kidney disease.
    Farooq Z, Behzadi AH, Blumenfeld JD, Zhao Y, Prince MR.
    Clin Imaging; 2018 Aug 01; 47():41-46. PubMed ID: 28846875
    [Abstract] [Full Text] [Related]

  • 36. Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging.
    Akbari P, Nasri F, Deng SX, Khowaja S, Lee SH, Warnica W, Lu H, Rattansingh A, Atri M, Khalili K, York P.
    Clin J Am Soc Nephrol; 2022 Jun 01; 17(6):827-834. PubMed ID: 35383043
    [Abstract] [Full Text] [Related]

  • 37. Imaging for the prognosis of autosomal dominant polycystic kidney disease.
    Bae KT, Grantham JJ.
    Nat Rev Nephrol; 2010 Feb 01; 6(2):96-106. PubMed ID: 20111050
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Automatic Segmentation of Kidneys using Deep Learning for Total Kidney Volume Quantification in Autosomal Dominant Polycystic Kidney Disease.
    Sharma K, Rupprecht C, Caroli A, Aparicio MC, Remuzzi A, Baust M, Navab N.
    Sci Rep; 2017 May 17; 7(1):2049. PubMed ID: 28515418
    [Abstract] [Full Text] [Related]

  • 40. Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.
    Lai S, Mastroluca D, Letizia C, Petramala L, Perrotta AM, DiGaeta A, Ferrigno L, Ciccariello M, D'Angelo AR, Panebianco V.
    Intern Med J; 2018 Dec 17; 48(12):1505-1513. PubMed ID: 30043487
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.